172 related articles for article (PubMed ID: 23515570)
1. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.
El-Moamly AA; El-Sweify MA; Rashad RM; Abdalla EM; Ragheb MM; Awad MM
Parasitol Res; 2013 Jul; 112(7):2745-52. PubMed ID: 23515570
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation.
Nattermann J; Timm J; Nischalke HD; Olbrich A; Michalk M; Tillmann HL; Berg T; Wedemeyer H; Tenckhoff H; Wiese M; Kullig U; Göbel U; Capka E; Schiefke I; Güthof W; Grüngreiff K; König I; Roggendorf M; Sauerbruch T; Spengler U;
J Hepatol; 2011 Dec; 55(6):1201-6. PubMed ID: 21703201
[TBL] [Abstract][Full Text] [Related]
3. CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.
Goyal A; Suneetha PV; Kumar GT; Shukla DK; Arora N; Sarin SK
World J Gastroenterol; 2006 Aug; 12(29):4721-6. PubMed ID: 16937446
[TBL] [Abstract][Full Text] [Related]
4. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
[TBL] [Abstract][Full Text] [Related]
5. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
[TBL] [Abstract][Full Text] [Related]
6. Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period.
Matos AR; Martins JSCC; Oliveira MLA; Garcia CC; Siqueira MM
Infect Genet Evol; 2019 Jan; 67():55-59. PubMed ID: 30389547
[TBL] [Abstract][Full Text] [Related]
7. CCR5Δ32 in HCV infection, HCV/HIV co-infection, and HCV-related diseases.
Ellwanger JH; Leal BK; Valverde-Villegas JM; Simon D; Marangon CG; Mattevi VS; Lazzaretti RK; Sprinz E; Kuhmmer R; Chies JAB
Infect Genet Evol; 2018 Apr; 59():163-166. PubMed ID: 29408489
[TBL] [Abstract][Full Text] [Related]
8. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the CCR5delta32 allele in hepatitis C.
Morard I; Clément S; Calmy A; Mangia A; Cerny A; De Gottardi A; Gorgievski M; Heim M; Malinverni R; Moradpour D; Müllhaupt B; Semela D; Pascarella S; Bochud PY; Negro F;
PLoS One; 2014; 9(9):e106424. PubMed ID: 25191700
[TBL] [Abstract][Full Text] [Related]
10. Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.
el-Kady IM; el-Masry SA; Badra G; Halafawy KA
Egypt J Immunol; 2004; 11(1):23-9. PubMed ID: 15724383
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
[TBL] [Abstract][Full Text] [Related]
12. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
[TBL] [Abstract][Full Text] [Related]
13. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
[TBL] [Abstract][Full Text] [Related]
14. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.
Kamal S; Madwar M; Bianchi L; Tawil AE; Fawzy R; Peters T; Rasenack JW
Liver; 2000 Jul; 20(4):281-9. PubMed ID: 10959806
[TBL] [Abstract][Full Text] [Related]
15. CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
Oh DY; Jessen H; Kücherer C; Neumann K; Oh N; Poggensee G; Bartmeyer B; Jessen A; Pruss A; Schumann RR; Hamouda O
PLoS One; 2008 Jul; 3(7):e2747. PubMed ID: 18648518
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
[TBL] [Abstract][Full Text] [Related]
17. Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.
Ruiz-Mateos E; Tarancon-Diez L; Alvarez-Rios AI; Dominguez-Molina B; Genebat M; Pulido I; Abad MA; Muñoz-Fernandez MA; Leal M
Antiviral Res; 2018 Feb; 150():15-19. PubMed ID: 29221798
[TBL] [Abstract][Full Text] [Related]
18. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
Thio CL; Astemborski J; Bashirova A; Mosbruger T; Greer S; Witt MD; Goedert JJ; Hilgartner M; Majeske A; O'Brien SJ; Thomas DL; Carrington M
J Virol; 2007 Jan; 81(2):441-5. PubMed ID: 17079285
[TBL] [Abstract][Full Text] [Related]
19. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
20. Effect of schistosomiasis and hepatitis on liver disease.
Halim AB; Garry RF; Dash S; Gerber MA
Am J Trop Med Hyg; 1999 Jun; 60(6):915-20. PubMed ID: 10403320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
